help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GÜNTHER, A.
Right arrow Articles by SEEGER, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GÜNTHER, A.
Right arrow Articles by SEEGER, W.

Am. J. Respir. Crit. Care Med., Volume 161, Number 2, February 2000, 454-462

Alveolar Fibrin Formation Caused by Enhanced Procoagulant and Depressed Fibrinolytic Capacities in Severe Pneumonia
Comparison with the Acute Respiratory Distress Syndrome

ANDREAS GÜNTHER, PARVIN MOSAVI, SABINE HEINEMANN, CLEMENS RUPPERT, HEIDI MUTH, PHILIPP MARKART, FRIEDRICH GRIMMINGER, DIETER WALMRATH, BETTINA TEMMESFELD-WOLLBRÜCK, and WERNER SEEGER

Department of Internal Medicine, Justus-Liebig-University, Giessen, Germany

Changes in the alveolar hemostatic balance in severe pneumonia were compared with those in the acute respiratory distress syndrome (ARDS). Analysis was performed in bronchoalveolar lavage fluids (BALF) of patients with ARDS triggered by nonpulmonary underlying events in the absence of lung infection (ARDS; n = 25), pneumonia demanding mechanical ventilation (PNEU-vent; n = 114), spontaneously breathing patients with pneumonia (PNEU-spon; n = 40), and ARDS in combination with lung infection (ARDS+PNEU; n = 43); comparison with healthy control subjects (n = 35) was performed. In all groups of patients, BALF total procoagulant activity was increased by nearly two orders of magnitude, being largely attributable to the tissue factor pathway of coagulation. Concomitantly, markedly reduced overall fibrinolytic capacity (fibrin plate assay) was noted in the lavage fluids of all patients. BALF levels of urokinase-type plasminogen activator were significantly reduced throughout, whereas the lavage concentrations of tissue-type plasminogen activator did not differ from those in control subjects. In addition, markedly enhanced levels of plasminogen activator- inhibitor I and alpha 2-antiplasmin were noted in ARDS, ARDS+PNEU, and PNEU-vent, but not in PNEU-spon. In all groups of patients, the changes in the lavage enzymatic activities were paralleled by manifold increased BALF concentrations of fibrinopeptide A and D-dimer, reflecting in vivo coagulation processes. Within the overall number of patients with pneumonia, changes in the alveolar hemostatic balance were more prominent in alveolar and interstitial pneumonia than in bronchopneumonia. Acute inflammatory lung injury, whether triggered by nonpulmonary systemic events or primary lung infection, is thus consistently characterized by both enhanced procoagulant and depressed fibrinolytic activities in the alveolar lining layer, with the appearance of fibrin formation in this compartment. Profile and extent of changes in severe pneumonia demanding respirator therapy are virtually identical to those in ARDS, whereas somewhat less prominent alterations of the alveolar hemostatic balance are noted in spontaneously breathing patients with pneumonia. Günther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbrück B, Seeger W. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia: comparison with the acute respiratory distress syndrome.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
K. Kambas, M. M. Markiewski, I. A. Pneumatikos, S. S. Rafail, V. Theodorou, D. Konstantonis, I. Kourtzelis, M. N. Doumas, P. Magotti, R. A. DeAngelis, et al.
C5a and TNF-{alpha} Up-Regulate the Expression of Tissue Factor in Intra-Alveolar Neutrophils of Patients with the Acute Respiratory Distress Syndrome
J. Immunol., June 1, 2008; 180(11): 7368 - 7375.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. A. D. van Zoelen, S. Florquin, J. C. M. Meijers, R. de Beer, A. F. de Vos, O. J. de Boer, and T. van der Poll
Platelet-Activating Factor Receptor Contributes to Host Defense against Pseudomonas aeruginosa Pneumonia but Is Not Essential for the Accompanying Inflammatory and Procoagulant Response
J. Immunol., March 1, 2008; 180(5): 3357 - 3365.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M. Wygrecka, P. Markart, L. Fink, A. Guenther, and K. T Preissner
Raised protein levels and altered cellular expression of factor VII activating protease (FSAP) in the lungs of patients with acute respiratory distress syndrome (ARDS)
Thorax, October 1, 2007; 62(10): 880 - 888.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Idell
Expression Profiling and Disseminated Intravascular Coagulation: Finding Genes Gone Wild
Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 528 - 530.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Wygrecka, R. E. Morty, P. Markart, S. M. Kanse, P. A. Andreasen, T. Wind, A. Guenther, and K. T. Preissner
Plasminogen Activator Inhibitor-1 Is an Inhibitor of Factor VII-activating Protease in Patients with Acute Respiratory Distress Syndrome
J. Biol. Chem., July 27, 2007; 282(30): 21671 - 21682.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M. J Schultz and M. Levi
Pulmonary coagulopathy: a potential therapeutic target in different forms of lung injury
Thorax, July 1, 2007; 62(7): 563 - 564.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. B. Allen, T. Leclair, M. Cloutier, J. Thompson-Figueroa, and J. H. T. Bates
The response to recruitment worsens with progression of lung injury and fibrin accumulation in a mouse model of acid aspiration
Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1580 - L1589.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Renckens, J. J. T. H. Roelofs, P. I. Bonta, S. Florquin, C. J. M. de Vries, M. Levi, P. Carmeliet, C. van't Veer, and T. van der Poll
Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia
Blood, February 15, 2007; 109(4): 1593 - 1601.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Dahlem, A. P. Bos, J. J. Haitsma, M. J. Schultz, E. K. Wolthuis, J. C. M. Meijers, and B. Lachmann
Mechanical ventilation affects alveolar fibrinolysis in LPS-induced lung injury
Eur. Respir. J., November 1, 2006; 28(5): 992 - 998.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. B. Ware, E. Camerer, K. Welty-Wolf, M. J. Schultz, and M. A. Matthay
Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury
Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L307 - L311.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
I. Vadasz, R. E. Morty, A. Olschewski, M. Konigshoff, M. G. Kohstall, H. A. Ghofrani, F. Grimminger, and W. Seeger
Thrombin Impairs Alveolar Fluid Clearance by Promoting Endocytosis of Na+,K+-ATPase
Am. J. Respir. Cell Mol. Biol., October 1, 2005; 33(4): 343 - 354.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. R. Bernard
Acute Respiratory Distress Syndrome: A Historical Perspective
Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 798 - 806.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G Choi, M J Schultz, M Levi, T van der Poll, J L Millo, and C S Garrard
Protein C in pneumonia
Thorax, August 1, 2005; 60(8): 705 - 706.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. van der Poll, M. Levi, J. A. Nick, and E. Abraham
Activated Protein C Inhibits Local Coagulation after Intrapulmonary Delivery of Endotoxin in Humans
Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1125 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
B. S. Burleson and E. D. Maki
Acute Respiratory Distress Syndrome
Journal of Pharmacy Practice, April 1, 2005; 18(2): 118 - 131.
[Abstract] [PDF]

Home page
 Occup. Environ. Med.Home page
P S Gilmour, E R Morrison, M A Vickers, I Ford, C A Ludlam, M Greaves, K Donaldson, and W MacNee
The procoagulant potential of environmental particles (PM10)
Occup. Environ. Med., March 1, 2005; 62(3): 164 - 171.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
G. Choi, M.J. Schultz, J.W.O. van Till, P. Bresser, J.S. van der Zee, M.A. Boermeester, M. Levi, and T. van der Poll
Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection
Eur. Respir. J., November 1, 2004; 24(5): 786 - 789.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
T. Nishiuma, T. H. Sisson, N. Subbotina, and R. H. Simon
Localization of Plasminogen Activator Activity within Normal and Injured Lungs by In Situ Zymography
Am. J. Respir. Cell Mol. Biol., November 1, 2004; 31(5): 552 - 558.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. M. Querol-Ribelles, J. M. Tenias, E. Grau, J. M. Querol-Borras, J. L. Climent, E. Gomez, and I. Martinez
Plasma d-Dimer Levels Correlate With Outcomes in Patients With Community-Acquired Pneumonia
Chest, October 1, 2004; 126(4): 1087 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. W. Rijneveld, S. Weijer, S. Florquin, C. T. Esmon, J. C. M. Meijers, P. Speelman, P. H. Reitsma, H. Ten Cate, and T. van der Poll
Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide
Blood, March 1, 2004; 103(5): 1702 - 1709.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M J Schultz, J Millo, M Levi, C E Hack, G J Weverling, C S Garrard, and T van der Poll
Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia
Thorax, February 1, 2004; 59(2): 130 - 135.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Gunther, N. Lubke, M. Ermert, R. T. Schermuly, N. Weissmann, A. Breithecker, P. Markart, C. Ruppert, K. Quanz, L. Ermert, et al.
Prevention of Bleomycin-induced Lung Fibrosis by Aerosolization of Heparin or Urokinase in Rabbits
Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1358 - 1365.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. W. Rijneveld, S. Florquin, P. Bresser, M. Levi, V. de Waard, R. Lijnen, J. S. Van der Zee, P. Speelman, P. Carmeliet, and T. van der Poll
Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia
Blood, August 1, 2003; 102(3): 934 - 939.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. Prabhakaran, L. B. Ware, K. E. White, M. T. Cross, M. A. Matthay, and M. A. Olman
Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury
Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L20 - L28.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. Fujimoto, E. C. Gabazza, O. Hataji, H. Yuda, C. N. D'Alessandro-Gabazza, M. Nakano, O. E. Franco, T. Hayashi, K. Suzuki, Y. Adachi, et al.
Thrombin-activatable Fibrinolysis Inhibitor and Protein C Inhibitor in Interstitial Lung Disease
Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1687 - 1694.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. H. Sisson, K. E. Hanson, N. Subbotina, A. Patwardhan, N. Hattori, and R. H. Simon
Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice
Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1023 - L1032.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Critical Care Medicine in AJRCCM 2000
Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1347 - 1361.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. IDELL
Anticoagulants for Acute Respiratory Distress Syndrome . Can They Work?
Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 517 - 520.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. T. Schermuly, A. Gunther, M. Ermert, L. Ermert, H. A. Ghofrani, N. Weissmann, F. Grimminger, W. Seeger, and D. Walmrath
Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation
Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L792 - L800.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
L. B. Ware and M. A. Matthay
The Acute Respiratory Distress Syndrome
N. Engl. J. Med., May 4, 2000; 342(18): 1334 - 1349.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2000 American Thoracic Society 		  ATS State of the Art Course 2008